Ian Davies
About Ian Davies
Ian Davies is the Vice President of Hematology Worldwide Value, Access, and Pricing at Bristol-Myers Squibb, with extensive experience in market access and pricing strategies for hematology and oncology products.
Current Role at Bristol-Myers Squibb
Ian Davies is the Vice President of Hematology Worldwide Value, Access, and Pricing at Bristol-Myers Squibb. Based in New Jersey, United States, he focuses on establishing and maintaining global pricing strategies to ensure market access for hematology products. Ian plays a critical role in collaborating with healthcare providers to ensure that investigational medicines are accessible in an equitable manner.
Previous Tenure at Celgene
Before his current role, Ian Davies held multiple significant positions at Celgene. From 2018 to 2019, he served as the Vice President, Head of Hematology and Oncology Global Pricing and Market Access. Prior to that, he was the Vice President, Corporate Pricing and Market Access from 2017 to 2018, and the Executive Director, Market Access Policy from 2016 to 2017. During his tenure at Celgene, Ian was instrumental in shaping market access policies, emphasizing the fair distribution of innovative medicines.
Experience at Novartis
Ian Davies has an extensive background with Novartis, where he held various positions over a decade. He contributed to the global product strategy for Exjade and managed patient and market access for the LatAm region. He also worked as the Senior Institutional Kam Novartis Oncology and Director of Brand Managed Markets for the U.S. team. Ian's work at Novartis included managing brand strategies for multiple products, particularly focusing on the U.S. and Latin American markets.
Education and Academic Background
Ian Davies holds a Master of Business Administration in Marketing from AGSIM - Thunderbird Graduate School of Management, which he earned between 1997 and 1998. He also has a Bachelor’s degree in International Relations from American University, completed between 1989 and 1993. His academic background, coupled with his extensive industry experience, provides a strong foundation for his roles in market access and pricing strategies.
Commitment to Patient Access and Safety
Ian Davies has consistently demonstrated a commitment to ensuring patient safety and equitable access to medicines. Throughout his career, he has supported patient assistance programs, contributed to the development of tiered pricing strategies to improve global access, and ensured that investigational medicines are provided fairly. His approach involves working closely with physicians and stakeholders to develop comprehensive market access strategies.